Helping pharmaceutical companies increase production efficiency and manage risk more effectively NEW YORK & CHICAGO--(BUSINESS WIRE)--Asahi Kasei Bioprocess America, subsidiary of diversified Japanese ...
In-line buffer management markedly reduced the production bottlenecks and manufacturing costs inherent in biopharmaceutical manufacturing. Additional cost reductions are possible, however, by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results